Literature DB >> 15230851

Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.

R Kannangai1, E Molmenti, L Arrazola, A Klein, M Choti, D L Thomas, M Torbenson.   

Abstract

Occult hepatitis B is defined by the presence of hepatitis B viral (HBV) DNA in the serum or liver in persons lacking hepatitis B surface antigen (HBsAg) in the serum. A high prevalence of occult HBV has been reported in hepatocellular carcinoma (HCC) from Asia, but little information is available on the prevalence of occult HBV in HCC from regions with a low prevalence of typical chronic hepatitis B infection. In a retrospective study, 19 cases of primary liver cancer were investigated for the presence of occult HBV DNA by amplification of the surface, core, and X gene. In addition, HBV copy numbers were quantitated by real time polymerase chain reaction, genotyped, and samples tested for covalently closed circular HBV DNA, which is a marker of active viral replication. Occult HBV was found in three of 19 cases (16%). Genotyping was successful in two cases, both of which were genotype A. HBV DNA copy numbers were low, all less than 10 copies/microg liver DNA. No closed circular HBV DNA was detected. Thus, in this study occult HBV was of genotype A and was found in a low percentage of cases of HCC and was associated with low tissue HBV DNA copy numbers and no detectable evidence for viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15230851     DOI: 10.1111/j.1365-2893.2004.00502.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  18 in total

1.  Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Arvind Reddy; Elizabeth May; Murray Ehrinpreis; Milton Mutchnick
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.

Authors:  Yan Gong; Yun-Sheng Yang; Xiao-Mei Zhang; Ming Su; Jean Wang; Jin-Dong Han; Ming-Zhou Guo
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

Review 3.  Occult hepatitis B virus infection in Egypt.

Authors:  Ashraf Elbahrawy; Alshimaa Alaboudy; Walid El Moghazy; Ahmed Elwassief; Ahmed Alashker; Abdallah Mahmoud Abdallah
Journal:  World J Hepatol       Date:  2015-06-28

4.  Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.

Authors:  Anna S Lok; James E Everhart; Adrian M Di Bisceglie; Hae-Young Kim; Munira Hussain; Timothy R Morgan
Journal:  Hepatology       Date:  2011-08       Impact factor: 17.425

5.  Association between hepatitis B virus and pancreatic cancer.

Authors:  Manal M Hassan; Donghui Li; Adel S El-Deeb; Robert A Wolff; Melissa L Bondy; Marta Davila; James L Abbruzzese
Journal:  J Clin Oncol       Date:  2008-10-01       Impact factor: 44.544

6.  Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

Authors:  C M Martin; J A Welge; N J Shire; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2009-11-02       Impact factor: 3.728

7.  Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Authors:  C M Martin; J A Welge; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2012-06-04       Impact factor: 3.728

8.  Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples.

Authors:  Perumal Vivekanandan; Rajesh Kannangai; Stuart C Ray; David L Thomas; Michael Torbenson
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

9.  A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.

Authors:  Atsunori Kusakabe; Yasuhito Tanaka; Etsuro Orito; Fuminaka Sugauchi; Fuat Kurbanov; Tomoyuki Sakamoto; Noboru Shinkai; Noboru Hirashima; Izumi Hasegawa; Tomoyoshi Ohno; Ryuzo Ueda; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

10.  Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.

Authors:  Brenda Y Hernandez; Xuemei Zhu; Sandi Kwee; Owen T M Chan; Naoky Tsai; Gordon Okimoto; David Horio; Katherine A McGlynn; Sean Altekruse; Linda L Wong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.